Jens Juul Holst

Jens Juul Holst


  1. Published

    Anti-diabetogenic effect of the human amylin analogue, pramlintide, in Type 1 diabetes is not mediated by GLP-1. / Ahrén, B; Adner, N; Svartberg, J; Petrella, E; Holst, Jens Juul; Gutniak, M K.

    In: Diabetic Medicine, Vol. 19, No. 9, 09.2002, p. 790-2.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 Next

ID: 4207